344 related articles for article (PubMed ID: 32741696)
1. Patient perceptions of pharmacogenomic testing in the community pharmacy setting.
Bright D; Worley M; Porter BL
Res Social Adm Pharm; 2021 Apr; 17(4):744-749. PubMed ID: 32741696
[TBL] [Abstract][Full Text] [Related]
2. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
[TBL] [Abstract][Full Text] [Related]
3. Applications for pharmacogenomics in pharmacy practice: A scoping review.
Hayashi M; Hamdy DA; Mahmoud SH
Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.
Jeiziner C; Meyer Zu Schwabedissen HE; Hersberger KE; Allemann SS
Int J Clin Pharm; 2023 Dec; 45(6):1378-1386. PubMed ID: 37338707
[TBL] [Abstract][Full Text] [Related]
5. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
[TBL] [Abstract][Full Text] [Related]
6. Designing a theory and evidence informed pharmacogenomic testing service in community pharmacy in England.
Rendell T; Barnett J; Scott S; Wright D
Res Social Adm Pharm; 2022 Oct; 18(10):3831-3838. PubMed ID: 35428579
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices.
Luke MJ; Krupetsky N; Liu H; Korenvain C; Crown N; Toenjes S; Sproule BA; Piquette-Miller M; Guirguis LM; McCarthy LM
Pharmacy (Basel); 2021 Dec; 9(4):. PubMed ID: 34941633
[TBL] [Abstract][Full Text] [Related]
8. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
[No Abstract] [Full Text] [Related]
9. Co-designing a community pharmacy pharmacogenomics testing service in the UK.
Rendell T; Barnett J; Wright D
BMC Health Serv Res; 2022 Mar; 22(1):378. PubMed ID: 35317803
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
Slomp C; Morris E; Edwards L; Hoens AM; Landry G; Riches L; Ridgway L; Bryan S; Austin J
Can J Psychiatry; 2023 Jun; 68(6):436-452. PubMed ID: 36437757
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada.
Maruf AA; Shields M; Fryza A; Wondrasek A; Leong C; Kowalec K; Bousman C
Pharmacogenomics; 2024 Mar; 25(4):175-186. PubMed ID: 38506345
[No Abstract] [Full Text] [Related]
12. Community pharmacists' experience with pharmacogenetic testing.
Moaddeb J; Mills R; Haga SB
J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
[TBL] [Abstract][Full Text] [Related]
13. An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students.
Mehtar M; Hammoud SH; Amin MEK
Saudi Pharm J; 2022 Dec; 30(12):1765-1772. PubMed ID: 36601506
[TBL] [Abstract][Full Text] [Related]
14. Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing.
Haga SB; Mills R; Moaddeb J; Liu Y; Voora D
Pharmgenomics Pers Med; 2021; 14():877-886. PubMed ID: 34290521
[TBL] [Abstract][Full Text] [Related]
15. How community pharmacists envision using pharmacogenomic data: A qualitative analysis.
Writer R; Barthen C; Antinopoulos B; Uber R; Stevenson JM; Berenbrok LA
J Am Pharm Assoc (2003); 2021; 61(5):e64-e70. PubMed ID: 33893058
[TBL] [Abstract][Full Text] [Related]
16. Community pharmacy teams' experiences of general practice-based pharmacists: an exploratory qualitative study.
Karampatakis GD; Patel N; Stretch G; Ryan K
BMC Health Serv Res; 2020 May; 20(1):431. PubMed ID: 32423485
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a pharmacogenetic educational toolkit for community pharmacists.
Haga SB; Mills R; Moaddeb J
Pharmacogenomics; 2016 Sep; 17(14):1491-502. PubMed ID: 27533631
[TBL] [Abstract][Full Text] [Related]
18. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
Haga SB; Moaddeb J; Mills R; Voora D
Pharmacogenomics; 2017 Mar; 18(4):327-335. PubMed ID: 28244804
[TBL] [Abstract][Full Text] [Related]
19. Patient and prescriber perceptions of depression screening within a community pharmacy setting.
Mospan CM; Gillette C; Wilson JA
J Am Pharm Assoc (2003); 2020; 60(5S):S15-S22. PubMed ID: 32280022
[TBL] [Abstract][Full Text] [Related]
20. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework.
Murry LT; Keller MS; Pevnick JM; Schnipper JL; Kennelty KA;
BMC Health Serv Res; 2022 Feb; 22(1):186. PubMed ID: 35151310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
